HIV susceptibility testing - Time for standards

Antiviral Therapy

Volumn 9, Issue 4, 2004, Pages 463-464

  Hill, Andrew M ^a   Telenti, Amalio ^b  

^a ROCHE PRODUCTS LTD   (United Kingdom)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ALGORITHM; ANTIVIRAL ACTIVITY; DISEASE PREDISPOSITION; DRUG MONITORING; EDITORIAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LABORATORY TEST; PRIORITY JOURNAL; STANDARD; VIRUS GENOME;

ANTI-HIV AGENTS; FUZZY LOGIC; GENOTYPE; HIV; HIV INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PRACTICE GUIDELINES;

EID: 4344654282     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (3)

1. Beaumont MA & Rannala B. The Bayesian revolution in genetics. Nature Reviews Genetics 2004; 5:251-261.
2. Telenti A, Beckmann JS & Mallal S. HLA and HIV: modeling adaptation to moving targets. Pharmacogenomics Journal 2003; 3:254-256.
3. May RM. Uses and abuses of mathematics in biology. Science 2004; 303:790-793.